Regarding the remaining DC populations, the favorable increased frequency of cDC2s observed in both TC-1 tumor and tumor-dLNs, known to contribute to CD4+ T-cell activation [39], matches the increased CD4+ T-cell proliferation observed after vaccination. This evidence concerns the gene CD4 and neoplasm.